Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Enclomiphene citrate (trans-Clomiphene citrate) 是口服具有活力的 oestrogen receptor 拮抗剂,具有抗雌激素活性。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 196 | 现货 | ||
5 mg | ¥ 460 | 现货 | ||
10 mg | ¥ 713 | 现货 | ||
25 mg | ¥ 1,080 | 现货 | ||
50 mg | ¥ 1,432 | 现货 | ||
100 mg | ¥ 2,150 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 595 | 现货 |
产品描述 | Enclomiphene citrate (trans-Clomiphene citrate) is a non-steroidal estrogen receptor antagonist,with antioestrogenic property |
体内活性 | total testosterone (TT) levels increased between baseline and after 16 weeks of treatment in all the treatment groups. FSH and LH levels increased in the enclomiphene citrate groups and decreased in the testosterone gel group at 16 weeks. Enclomiphene citrate maintained sperm concentration in the normal range over the treatment period, while there was a marked reduction in spermatogenesis in the testosterone gel group[1]. |
动物实验 | Two parallel randomised, double-blind, double-dummy, placebo-controlled, multicentre, phase III studies were undertaken to evaluate two doses of enclomiphene citrate vs testosterone gel on total testosterone (TT), LH, FSH, and sperm counts in overweight men aged 18-60 years with secondary hypogonadism. Men were screened and enrolled in the trials (ZA-304 and ZA-305). All enrolled men had early morning serum TT levels in the low or low normal range (≤300 ng/dL; ≤10.4 nmol/L) and had low or normal LH (<9.4 IU/L) levels measured on two separate occasions 2-10 days apart. Serum samples were obtained over the course of the study to determine relevant hormone levels at baseline and after 16 weeks of treatment. Men provided semen samples twice to enroll at the beginning and twice at the end of the study[1]. |
别名 | 恩氯米芬柠檬酸盐, Enclomifene citrate, (E)-Clomiphene citrate, trans-Clomiphene citrate |
分子量 | 598.08 |
分子式 | C32H36ClNO8 |
CAS No. | 7599-79-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (83.60 mM)
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.672 mL | 8.3601 mL | 16.7202 mL | 41.8004 mL |
5 mM | 0.3344 mL | 1.672 mL | 3.344 mL | 8.3601 mL | |
10 mM | 0.1672 mL | 0.836 mL | 1.672 mL | 4.18 mL | |
20 mM | 0.0836 mL | 0.418 mL | 0.836 mL | 2.09 mL | |
50 mM | 0.0334 mL | 0.1672 mL | 0.3344 mL | 0.836 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
Enclomiphene citrate 7599-79-3 Endocrinology/Hormones Estrogen Receptor/ERR testosterone deficiency Inhibitor 恩氯米芬柠檬酸盐 trans-Clomiphene testosterone Hypogonadal trans-Clomiphene Citrate hormone ovarian dysfunction Enclomifene Citrate Enclomiphene Citrate inhibit Enclomifene Clomiphene Citrate hypogonadism (E)-Clomiphene Enclomifene citrate estrogen receptor modulator Enclomiphene (E)-Clomiphene citrate trans-Clomiphene citrate inhibitor